Results 121 to 130 of about 6,032 (181)

In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors [PDF]

, 2015

core   +1 more source

Copper-promoted oxidative mono- and di-bromination of 8-aminoquinoline amides with HBr and DMSO. [PDF]

RSC Adv
Shao C, Liu J, Shen Y, Li L, Ma C, Hu Z, Kan Y, Chen P, Zhang T.   +8 more
europepmc   +1 more source

Reactions between 8-aminoquinoline and metal ions and volumetric determination of 8-aminoquinoline

BUNSEKI KAGAKU, 1970
Katsumi YAMAMOTO, Yasutoshi NODA
openaire   +2 more sources

Molecular Mediated Angiogenesis and Vasculogenesis Networks. [PDF]

Int J Mol Sci
Lungu CN, Mangalagiu II, Romila A, Nechita A, Putz MV, Mehedinti MC.   +5 more
europepmc   +1 more source

Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics. [PDF]

Lancet Infect Dis
Ciavarella C, Drakeley C, Price RN, Mueller I, White M.   +4 more
europepmc   +1 more source

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama. [PDF]

Front Pharmacol
Quijada M, Castillo-Bultron M, Díaz Y, Pitti Y, Franco D, De La Guardia C, Campos D, Cornejo E, Núñez M, Mendoza L, López-Vergès S, Magallon-Tejada AH, Obaldia N.   +12 more
europepmc   +1 more source

Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant <i>Plasmodium falciparum</i>. [PDF]

J Med Chem
Handford MJ, Li Y, Riscoe T, Liebman KM, Zhang X, Kelly JX, Riscoe MK.   +6 more
europepmc   +1 more source

Radical Cure of Plasmodium Vivax Malaria: How can we Improve 8-Aminoquinoline Implementation? [PDF]

Ethiop J Health Sci
Yilma D.
europepmc   +1 more source

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria. [PDF]

Malar J
Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, Domingo GJ, Gibson RA, Rolfe K, Tan L, Fiţa IG, Chen C, Bird P, Pingle A, Duparc S.   +12 more
europepmc   +1 more source